STAT

APRIL 10, 2024

Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.

Immunization 144

Immunization 144

Pharmacy Times

JULY 26, 2024

Study finds traces of “epigenetic scars” on the immune cells of patients who recovered from chronic hepatitis C infection.

Immunization 130

Immunization 130

Pharmacy Times

AUGUST 9, 2023

Chad Worz, PharmD, BCGP, FASCP, discusses how vaccine hesitancy and misinformation about flu vaccines create barriers to annual flu immunizations.

Immunization 120

Immunization Vaccines 120

Pharmacy Times

AUGUST 16, 2023

Experts discuss the social determinants that can affect the rates of flu immunizations and strategies to boost immunization rates.

Immunization 123

Immunization 123

Drug Topics

MAY 21, 2024

Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.

Immunization 112

Immunization Vaccines 112

pharmaphorum

MAY 22, 2024

Immune checkpoint enhancer biotech AltruBio raises $225m to support phase 2 trials of its PSGL-1-targeted drug for ulcerative colitis

Immunization 105

Immunization 105

Drug Topics

APRIL 9, 2024

Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.

Immunization 154

Immunization 154

Outsourcing Pharma

AUGUST 27, 2024

The INNA-051 formulation is designed to enhance the bodyâs natural immune response, targeting individuals aged 60 and over who are at increased risk for complications from respiratory viral infections.

Immunization 82

Immunization 82

STAT

MARCH 27, 2024

Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “ twilight of immunity. ” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

Immunization 139

Immunization 139

Pharmacy Times

JULY 30, 2024

Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.

Immunization 139

Immunization 139

STAT

FEBRUARY 14, 2024

The study , published Wednesday in Nature, underscores the importance of never lighting up that first cigarette, based on its conclusion that smoking has much longer harmful effects on immune responses than previously understood. Read the rest…

Immunization 145

Immunization 145

Pharmacy Times

JUNE 4, 2024

The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members

Immunization 149

Immunization Community Pharmacies 149

Pharmacy Times

SEPTEMBER 21, 2023

Two separate study findings reported that a subset of dormant CD4+ cells could spontaneously produce HIV RNA and proteins, impacting a patient’s HIV-specific immune responses.

Immunization 137

Immunization 137

Pharmacy Times

AUGUST 26, 2024

Building trust between techs and patients makes administering vaccines easier and increase immunizers’ confidence.

Immunization 73

Immunization Vaccines 73

Pharmacy Times

AUGUST 2, 2023

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Immunization 123

Immunization Vaccines 123

Pharmacy Times

JANUARY 2, 2024

The new understanding of immune cells could not only contribute to the development of lung disease treatments, but treatments for other organ systems as well.

Immunization 148

Immunization 148

pharmaphorum

NOVEMBER 1, 2024

The 8th Antigen-Specific Immune Tolerance Drug Development Summit is an event organised by Hanson Wade. Discover the latest developments and networking opportunities at this leading industry conference.

Immunization 52

Immunization 52

Pharmafile

JULY 30, 2024

Biopharmaceutical company Boehringer Ingelheim has announced the acquisition of drug discovery and development company Nerio Therapeutics for up to $1.3bn, with the aim to develop Nerio’s novel immune checkpoint inhibitors.

Immunization 64

Immunization 64

STAT

OCTOBER 13, 2023

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

Immunization 145

Immunization 145

Hospital Pharmacy Europe

OCTOBER 25, 2024

A study has identified subtle changes in how immune cells respond to different severe febrile illnesses in children, which could lead to improved treatments. In the clinic currently, our treatments for dysfunctional immunity are poor and not targeted to individual children.

Immunization 52

Immunization Hospitals Communication 52

STAT

FEBRUARY 28, 2024

The ads, which tell parents to contact their general practitioners if they’ve missed getting their kids immunized, are designed to capture parents’ desires to keep kids safe. Read the rest…

Immunization 145

Immunization Vaccines 145

Drug Topics

OCTOBER 21, 2024

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

Immunization 201

Immunization Vaccines 201

STAT

OCTOBER 6, 2023

If the Covid-19 pandemic has shown us one thing, it is how little we really know about how the human immune system works. Decoding and harnessing the power of the human immune system is one of the great frontiers of biomedicine.

Immunization 140

Immunization Vaccines 140

pharmaphorum

JANUARY 22, 2024

End of the line for Roche’s 18-year alliance with Swiss biotech AC Immune, as it returns rights to Alzheimer's antibodies crenezumab and semorinemab

Immunization 106

Immunization 106

STAT

JUNE 10, 2024

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

Immunization 144

Immunization Vaccines 144

Pharmacy Times

DECEMBER 13, 2023

Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.

Immunization 139

Immunization Vaccines 139

STAT

MAY 21, 2024

Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers.

Immunization 125

Immunization 125

Pharmacy Times

JULY 22, 2022

Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.

Immunization 132

Immunization 132

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Immunization 59

Immunization 59

European Pharmaceutical Review

MARCH 6, 2023

Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection.

Immunization 103

Immunization Vaccines Communication 103

Drug Store News

DECEMBER 1, 2022

Immune Booster features PreforPro, a probiotic that looks to help balance the gut microbiota, the company said.

Immunization 94

Immunization 94

Pharmacy Times

JUNE 13, 2023

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

Immunization 123

Immunization Vaccines 123

Pharmacy Times

OCTOBER 11, 2022

Study data showed that more than three-quarters of patients with dermatomyositis who received intravenous immune globulin therapy experienced improved symptoms.

Immunization 132

Immunization 132

European Pharmaceutical Review

OCTOBER 20, 2022

Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?mediated What are Tregs and how are they applicable to immune-mediated disease?

Immunization 140

Immunization 140

Pharmacy Times

AUGUST 29, 2024

By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.

Immunization 73

Immunization Vaccines 73

European Pharmaceutical Review

AUGUST 8, 2024

An investigational, individualised neoantigen therapy, with personalised encoded mRNA, has demonstrated potential to enable patient’s immune system to target cells that cause cancer. Melanoma patients were treated with both mRNA-4157 (V940) and the immune checkpoint inhibitor pembrolizumab.

Immunization 52

Immunization 52

Hospital Pharmacy Europe

JULY 11, 2024

In a letter published in The Lancet , researchers from the University of Birmingham highlighted the ‘concerning gap’ in measles immunity among healthcare workers in the UK, with as many as one in five not fully immunised against the infection. In both cohorts, the researchers found that measles immunity is currently suboptimal.

Immunization 59

Immunization Hospitals Vaccines Patient Care 59